Download citation
Download citation
addenda and errata
1′-Phenyl-2′,3′,5′,6′,7′,7a′-hexahydroindan-2-spiro-2′-1H-pyrrolizine-3′-spiro-11′-indeno[1,2-b]quinoxaline-1,3-dione. Corrigendum
aDepartment of Crystallography and Biophysics, University of Madras, Guindy Campus, Chennai 600 025, India, bLaboratory of X-ray Crystallography, Indian Institute of Chemical Technology, Hyderabad 500 007, India, and cDepartment of Organic Chemistry, University of Madras, Guindy Campus, Chennai 600 025, India
*Correspondence e-mail: d_velu@yahoo.com
(Received 7 October 2005; accepted 8 October 2005; online 15 October 2005)
In the paper by Gayathri, Aravindan, Velmurugan, Ravikumar & Sureshbabu [Acta Cryst. (2005), E61, o3124–o3126], the formula is given incorrectly in the Abstract. The correct formula is C35H25N3O2.